§ Funding Round
iRegene Therapeutics raised $42.1M Series B venture round, led by chuangjing capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$42.1M
Top Valuation
-
iRegene Therapeutics raised $42.1M in a Series B round.
The round was announced on 09/09/25.
The round was led by chuangjing capital, Northern Light Venture Capital, onehealth haihe capital.
